The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden.

MLA

Bolin, Kristian, et al. “The Cost-Effectiveness of Growth Hormone Replacement Therapy (Genotropin®) in Hypopituitary Adults in Sweden.” Cost Effectiveness and Resource Allocation : C/E, vol. 11, no. 1, Sept. 2013, p. 24. EBSCOhost, https://doi.org/10.1186/1478-7547-11-24.

APA

Bolin, K., Sandin, R., Koltowska-Häggström, M., Loftus, J., Prütz, C., & Jonsson, B. (2013). The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden. Cost Effectiveness and Resource Allocation : C/E, 11(1), 24. https://doi.org/10.1186/1478-7547-11-24

Chicago

Bolin, Kristian, Rickard Sandin, Maria Koltowska-Häggström, Jane Loftus, Christin Prütz, and Björn Jonsson. 2013. “The Cost-Effectiveness of Growth Hormone Replacement Therapy (Genotropin®) in Hypopituitary Adults in Sweden.” Cost Effectiveness and Resource Allocation : C/E 11 (1): 24. doi:10.1186/1478-7547-11-24.